Results 151 to 160 of about 35,587 (246)

Contemporary Precision Stratification and Prognostic Features of Primary Gliomas in a Southern Chinese Population. [PDF]

Research (Wash D C)
Qu S, Ye Z, Pan Q, Xu H, Li H, Wang J, Zhang X, Ainiwan Y, Wang L, Yi G, Lin J, Li Z, Zheng X, Xie T, Huang Y, Liu T, Zhang X, Qi S, Huang G.   +18 more
europepmc   +1 more source

IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction—a retrospective propensity score analysis [PDF]

, 2020
Badder Kattih, Amir Shirvani, Piroska Klement, Abel Martin Garrido, Razif Gabdoulline, Alessandro Liebich, Maximilian Brandes, Anuhar Chaturvedi, Timon Seeger, Felicitas Thol, Gudrun Göhring, Brigitte Schlegelberger, Robert Geffers, David John, Udo Bavendiek, Johann Bauersachs, Arnold Ganser, Joerg Heineke, Michael Heuser   +18 more
openalex   +1 more source

IDH1 NP_005887.2:p.R132V [PDF]

, 2020
openaire   +1 more source

Deacetylated MDH1 and IDH1 aggravates PANoptosis in acute liver failure through endoplasmic reticulum stress signaling [PDF]

Chunxia Shi, Yukun Wang, Guo Jin, Danmei Zhang, Yanqiong Zhang, Zuojiong Gong   +5 more
openalex   +1 more source

Analysis of TET-2, ASXL1, IDH1, IDH2 Gene Polymorphisms and The Correlation with Clinical Parameters in Patients With Myelodysplastic Syndrome

, 2020
Gülay Alp
openalex   +1 more source

The hypermethylation of the O⁶‐methylguanine‐DNA methyltransferase gene promoter in gliomas—correlation with array comparative genome hybridization results and IDH1 mutation [PDF]

, 2011
Katja Tuononen, Olli Tynninen, Virinder Kaur Sarhadi, A. Tyybäkinoja, Mikael Lindlöf, Miia Antikainen, Juha Näpänkangas, Ari Hirvonen, Hanna Mäenpää, Anders Paetau, Sakari Knuutila   +10 more
openalex   +1 more source

Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors

, 2022
Jan Philipp Bewersdorf, Rory M. Shallis, Andriy Derkach, Aaron D. Goldberg, Anthony S. Stein, Eytan M. Stein, Guido Marcucci, Amer M. Zeidan, Shai Shimony, Daniel J. DeAngelo, Richard M. Stone, Ibrahim Aldoss, Brian Ball, Maximilian Stahl   +13 more
openalex   +2 more sources

PARP inhibitor resistance in IDH1-mutant cancers due to loss of end protection factors, 53BP1 and REV7. [PDF]

NAR Cancer
Colón-Ríos DA, Dow J, Krysztofiak A, Liu Y, Rogers FA, Glazer PM.   +5 more
europepmc   +1 more source

Autocrine BMP4 Signaling Enhances Tumor Aggressiveness via Promoting Wnt/β-Catenin Signaling in IDH1-mutant Gliomas

, 2019
Yiqiang Zhou, Yang Liu, Junwen Zhang, Di Yu, Aiguo Li, Hua Song, Wei Zhang, Dionne Davis, Mark R. Gilbert, Fusheng Liu, Chunzhang Yang   +10 more
openalex   +1 more source

Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas withIDH1Mutation [PDF]

, 2015
Yinyan Wang, K. Wang, S.W. Li, J.F. Wang, Jun Ma, Tao Jiang, Jianping Dai   +6 more
openalex   +1 more source